Skye Bioscience to Present at TD Cowen Health Care Conference
Skye Bioscience, Inc. (SKYE)
Company Research
Source: GlobeNewswire
SAN DIEGO, Calif., Feb. 20, 2025 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biopharmaceutical company focused on unlocking new therapeutic pathways for obesity and other metabolic health disorders, today announced that Punit Dhillon, Chief Executive Officer, will present a corporate overview and be available for 1x1 meetings at the TD Cowen 45th Annual Health Care Conference. Presentation Date: Wednesday, March 5, 2025Time: 11:10 AM – 11:40 AM ETLocation: Boston, MA A live and archived webcast will be accessible on Skye’s website. About Skye Bioscience Skye is focused on unlocking new therapeutic pathways for metabolic health through the development of next-generation molecules that
Read more
Impact Snapshot
Event Time:
SKYE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SKYE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SKYE alerts
High impacting Skye Bioscience, Inc. news events
Weekly update
A roundup of the hottest topics
SKYE
News
- Skye Bioscience, Inc. (NASDAQ: SKYE) had its price target lowered by analysts at Craig Hallum from $18.00 to $14.00. They now have a "buy" rating on the stock.MarketBeat
- Skye Bioscience, Inc. (NASDAQ: SKYE) had its "outperform" rating re-affirmed by analysts at William Blair.MarketBeat
- Skye Bioscience, Inc. (SKYE) Q4 2024 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- Skye Bioscience Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update [Yahoo! Finance]Yahoo! Finance
- Skye Bioscience Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business UpdateGlobeNewswire
SKYE
Earnings
- 3/20/25 - Beat
SKYE
Sec Filings
- 3/20/25 - Form S-8
- 3/20/25 - Form 8-K
- 3/20/25 - Form 10-K
- SKYE's page on the SEC website